NN Blokhin Russian Cancer Research Center

Moscow 115478

0 studies enrolling now · 7 studies all time

What they study most

ALK+ Advanced NSCLC, Breast Cancer With Low to Intermediate HER2 Expression, Carcinoma, Pancreatic Ductal, Indolent Non-Hodgkin's Lymphomas, Metastatic Colorectal Cancer, Refractory Metastatic Gastric Cancer, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Soft Palate

Studies at this site

• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity — Completed
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early
• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed
• A Non-Interventional Follow-Up to the VELOUR Study - Translational Research — Status unconfirmed